Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Akebia Therapeutics (AKBA) Long-Term Debt Repayments (2016 - 2025)

Akebia Therapeutics has reported Long-Term Debt Repayments over the past 7 years, most recently at $462000.0 for Q1 2025.

  • Quarterly Long-Term Debt Repayments fell 98.74% to $462000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $462000.0 through Dec 2025, down 98.75% year-over-year, with the annual reading at $462000.0 for FY2025, 98.75% down from the prior year.
  • Long-Term Debt Repayments was $462000.0 for Q1 2025 at Akebia Therapeutics, up from -$1000.0 in the prior quarter.
  • Over five years, Long-Term Debt Repayments peaked at $36.7 million in Q1 2024 and troughed at -$1000.0 in Q4 2024.
  • The 4-year median for Long-Term Debt Repayments is $8.0 million (2023), against an average of $12.8 million.
  • The largest YoY upside for Long-Term Debt Repayments was 129.54% in 2024 against a maximum downside of 100.01% in 2024.
  • A 4-year view of Long-Term Debt Repayments shows it stood at $33.0 million in 2022, then crashed by 75.76% to $8.0 million in 2023, then tumbled by 100.01% to -$1000.0 in 2024, then soared by 46300.0% to $462000.0 in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Long-Term Debt Repayments are $462000.0 (Q1 2025), -$1000.0 (Q4 2024), and $374000.0 (Q2 2024).